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Summary
Objective: To evaluate the acceptability, reliability, validity and responsiveness of the Turkish version of Western Ontario and McMaster
Universities (WOMAC) osteoarthritis (OA) index in physiotherapy outpatient practice in Turkey.
Method: Data were obtained from 72 patients with OA of the knee. They were asked to answer two disease-speciﬁc questionnaires (WOMAC
LK 3.1 and Lequesne-Algofunctional Index of Severity for the knee) and one generic instrument (Medical outcomes study SF-36 Survey-SF-
36). Acceptability was assessed in terms of refusal rate, rates of missing responses, and administration time. Reliability was assessed using
Cronbach’s alpha. Content validity was assessed by examining the ﬂoor and ceiling effects, and skew of the distributions. Convergent and
divergent validity was assessed by examining the Pearson’s correlation coefﬁcients. Responsiveness was determined by examining effect
size (ES), standardized response means (SRM) and P values generated using Wilcoxon’s test.
Results: The overall response rate was 100%. Alpha values for all WOMAC subscales exceeded the value of 0.70 at both baseline and follow-
up assessments. Frequency distributions of scores were symmetrical. Subscales had negligible ﬂoor and ceiling effects. Both pain and
physical function subscales were fairly correlated with the subscales measuring similar constructs of SF-36, whereas they were weakly
correlated with other dimensions of SF-36. A good correlation was obtained between WOMAC total and Lequesne index. The pain and
physical function subscales of WOMAC index were the most responsive subscales.
Conclusion: The Turkish WOMAC OA index is acceptable, valid, reliable and responsive for use in Turkish patients with knee OA.
ª 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Evaluation has always been an important component of any
health intervention program. The impact of chronic disease
and therapeutic interventions must be evaluated from the
patient’s perspective in addition to more traditional meas-
ures of medical outcomes1. Patient-based outcome meas-
ures, addressing constructs such as health-related quality
of life, subjective health status and functional status, are
increasingly used as primary or secondary end-points in
clinical trials. These instruments, if proved and valid, offer
an important additional information source to clinicians in
the care of their patients2,3.
Various clinical instruments can be used to assess the
patients with knee osteoarthritis (OA). The Western Ontario
and McMaster Universities (WOMAC) OA index is the most
widely used disease-speciﬁc instrument for assessment of
patients with OA4,5. It is recommended by Outcome
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measure the dimension of function in OA trials6. It has been
argued that cross-cultural validation of patient-based out-
come measures are needed to compare and contrast
results, aggregate data from different countries, strengthen
causal inference on effects of treatments, and to investigate
the natural history of health conditions.
Although there was a linguistically validated Turkish
version of WOMAC index, there is no available literature
that suggests this version of WOMAC index is culturally
equivalent to the original questionnaire, and has a similar
level of validity and reliability in patients with knee OA. The
aim of the present study was to evaluate the acceptability,
reliability, validity and responsiveness of the Turkish version
of WOMAC index in physiotherapy outpatient practice in
Turkey.
Method
SUBJECTS
Seventy-two consecutive knee OA patients on the waiting
list at the Department of Physical Medicine and Rehabili-
tation at Basxkent University Hospital in Ankara, Turkey,
were asked to be study subjects. Patients were recruited8
29Osteoarthritis and Cartilage Vol. 13, No. 1from February to June 2003. Inclusion criteria for the study
were age over 40 years and primary knee OA. All patients
fulﬁlled clinical and radiological criteria of the American
College of Rheumatology for primary knee OA7. Disease
severity was graded on the basis of the Kellegren and
Lawrence radiographic system8. Exclusion criteria included
history or active presence of other rheumatic diseases
potentially responsible for a secondary OA, severe articular
inﬂammation as conﬁrmed by physical examination and
laboratory parameters (ESRO 40 mm/h and serum
rheumatoid factor titer O1:40), traumatic knee lesions,
intra-articular or systemic use of corticosteroids within
the previous 3 months, and use of analgesics and non-
steroidal anti-inﬂammatory drugs during the previous 2
months. Patients who had advanced cardiac diseases or
peripheral vascular diseases were also excluded from the
study.
Subjects were randomly allocated to two groups. The ﬁrst
group (nZ 36) received isokinetic quadriceps exercise
program. The second group (nZ 36) received isotonic
quadriceps exercise program. Patients in both intervention
groups also received transcutaneous electrical nerve
stimulation and hot packs application. Treatment was
administered ﬁve times a week for 2 weeks in both groups.
In addition to demographic data, patients were asked to
report co-morbid conditions such as chronic respiratory
disease, hypertension, gastrointestinal disease and endo-
crine disease. The full details of this randomized trial of
isotonic vs isokinetic quadriceps strengthening were pre-
sented elsewhere9.
The ethics committee of Basxkent University approved the
study. Each patient was informed about the study and they
gave their written informed consent to participate.
INSTRUMENTS
Patients were assessed for functional ability and general
health status, using two disease-speciﬁc questionnaires
(WOMAC index and Lequesne-Algofunctional Index of
Severity for the knee) and one general health questionnaire
(Medical Outcomes Study Short Form (SF-36). Disease-
speciﬁc questionnaires were administered at baseline
(Time 1) and on the third day after treatment period (Time
2), whereas the SF-36 was administered at baseline. The
WOMAC index and the SF-36 were ﬁlled out by patients in
the same room in the clinic. The third investigator (AA)
ﬁlled out the Lequesne index using interview technique.
Time taken to ﬁll out WOMAC index and SF-36 was
recorded.
The WOMAC index is a disease-speciﬁc, self-adminis-
tered questionnaire developed to study patients with hip or
knee OA. It consists of 24 questions, grouped into 3
subscales (pain, stiffness, and physical function)10. In this
study, after obtaining permission from the copyright owner
(Dr Nicholas Bellamy), we used linguistically validated
Turkish version of WOMAC LK 3.1 scale. In Likert (LK)
scale, there are ﬁve alternative answers to every question
(0Z none, 1Zmild, 2Zmoderate, 3Z severe, 4Z ext-
reme). The maximum score in LK scale is 20 points for pain,
8 points for stiffness, and 68 points for physical function.
Higher scores indicate more or worse symptoms, maximal
limitations, and poor health. In this study, we used
a normalization procedure to correct for differences in scale
length. In order to normalize the LK scale on a scale of
0e10, the following correction factors were used where
SZ sum of raw scores of items in dimension: Pain nor-
malizationZS! 0.50; Stiffness normalizationZ S! 1.25;and Physical function normalizationZS! 0.14711. After
subscale values were normalized, they were summated to
provide a single value in which the three component sub-
scales were equally weighted (WOMAC total score)11.
Lequesne-Algofunctional Index of Severity for the knee is
a disease-speciﬁc questionnaire. It consists of 10 questions
grouped into three subscales (pain or discomfort, activities
of daily living and maximum distance walked). Although the
metric properties of the Lequesne index have been estab-
lished12,13, separate subscales have not been validated for
independent applications14. Total score ranges from 0 to 24,
and higher scores indicate more severe handicap.
In this study, after we obtaining permission from the
copyright owner (QualityMetric Incorporated), Turkish ver-
sion of the SF-36 was used to assess the general health
status of subjects. The SF-36 includes eight multi-item
scales containing two to 10 items each plus a single item to
compare the current health with a person’s health one year
ago (health transition)15. The scales cover the dimensions
of physical functioning (PF), role physical (RP), bodily pain
(P), general health (GH), vitality (V), social functioning (SF),
role emotional (RE), and mental health (MH). All items
pertaining to each scale (excluding health transition) are
summed and transformed to form a scale from 0 to 100,
where a higher score indicates a better state of health or
well-being.
ANALYSIS
In this study, we used the Statistical Package for the
Social Sciences (SPSS for Windows 9.0) for statistical
analyses. We checked the missing values for each
questionnaire prior to further analysis. To evaluate the
association between the WOMAC index subscales and
patient characteristics, such as age, marital status, level of
education, body-mass index (BMI), duration of OA and
radiographic severity, correlation coefﬁcients were calcu-
lated. Acceptability was assessed in terms of refusal rate,
rates of missing responses and administration time.
Internal consistency reliability was assessed by Cronba-
ch’s alpha coefﬁcient at Time 1 and Time 2. An alpha value
of 0.70 or higher was considered as acceptable reliability for
group comparisons16,17.
Content validity was assessed at Time 1 by examining
the ﬂoor and ceiling effects, and skew of the distribution in
each subscale. We hypothesized that the skewness
statistics range from 1 to C118, and ﬂoor and ceiling
effects are less than 20%19.
Convergent and divergent construct validity was as-
sessed at Time 1 by examining the Pearson’s correlation
coefﬁcients of the WOMAC index subscales compared to
the subscales of SF-36. We also examined the correlation
coefﬁcient between WOMAC total and Lequesne index.
Based on the literature, we hypothesized that WOMAC pain
and physical function (and lesser extent stiffness) scores
are highly correlated with similar subscale (physical function
and bodily pain) scores derived from SF-365. We further
hypothesized that WOMAC total is highly correlated with
Lequesne index (convergent validity)20. Additionally, we
hypothesized that WOMAC index subscales are inade-
quately or weakly correlated with theoretically unrelated
subscale (mental component subscales) scores derived
from SF-36 (divergent validity). Pearson’s correlation
coefﬁcients were interpreted as either excellent relationship
jrj R 0.91; good 0.90 R jrj R 0.71; fair 0.70 R jrj R
0.51; weak 0.50 R jrj R 0.31; little or none jrj% 0.3. A
P value of 0.01 was taken as the level of signiﬁcance21.
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Baseline characteristics of study population
Characteristics Isotonic exercise
group (NZ 36)
Isokinetic exercise
group (NZ 36)
Total (NZ 72)
Sex (female), n (%) 31 (86.1) 31 (86.1) 62 (86.1)
Age, mean (SD), years 61.9 (8.9) 60.2 (9.2) 61.0 (9.0)
Marital status, n (%)
Married 26 (72.2) 22 (61.1) 48 (66.7)
Single 10 (27.8) 14 (38.9) 24 (33.3)
BMI, mean (SD), kg/m2 29.5 (5.3) 30.2 (4.6) 29.8 (4.9)
Education level, n (%)
Primary level 11 (30.6) 5 (13.9) 16 (22.2)
Secondary level 4 (11.1) 4 (11.1) 8 (11.1)
High school level 11 (30.6) 16 (44.4) 27 (37.5)
University 10 (27.8) 11 (30.6) 21 (29.2)
Duration of OA, mean (SD), years 6.1 (6.1) 4.7 (4.5) 5.4 (5.3)
Radiological grade, n (%)
Grade 1 9 (25.0) 13 (36.1) 22 (30.6)
Grade 2 18 (50.0) 12 (33.3) 30 (41.7)
Grade 3 8 (22.2) 8 (22.2) 16 (22.2)
Grade 4 1 (2.8) 3 (8.3) 4 (5.6)
Number of co-morbid conditions, n (%)
0 10 (27.8) 13 (36.1) 23 (31.9)
1 21 (58.3) 10 (27.8) 31 (43.1)
2 or more 5 (13.9) 13 (36.1) 18 (25.0)Responsiveness was determined by examining the P
values generated using Wilcoxon’s test comparing Time 1
scores with Time 2 scores. We also examined the effect
size (ES) and standardized response means (SRM). The
ES is equal to the mean change in score divided by the
standard deviation of individuals’ baseline (Time 1) score.
The SRM is equal to the mean change in score divided by
the standard deviation of individuals’ changes in score. A
value of 0.2 to 0.5 was regarded as ‘‘small’’, 0.5 to 0.8 as
‘‘medium’’, and those above 0.8 as ‘‘large’’22.
Results
As shown in Table I, the majority of patients were women
(86%). The mean age of 72 patients was 61.0G 9 years
(range 41e80). The mean duration of OA was 5.4G 5.3
years (range 6 monthse20 years). Thirty-two patients
(44.4%) were obese (BMIO 30.0 kg/m2), another 27
(37.5%) were overweight (BMIZ 25.0e29.9 kg/m2). Forty-
nine patients (68.1%) reported one or more co-morbid
conditions. Distribution of radiographic severity showed that
majority of patients had a radiological severity of ﬁrst and
second degree on Kellegren’s scale (30.6% and 41.7%,
respectively).
Table II
Correlation coefficients between the WOMAC scores and in-
dependent variables
Independent
variables
WOMAC subscales
Pain Stiffness Physical
function
Total
Pearson
Age 0.03 0.05 0.07 0.04
BMI 0.08 0.16 0.17 0.17
Duration of disease 0.14 0.11 0.03 0.01
Spearman
Marital status 0.17 0.08 0.09 0.11
Education level 0.14 0.03 0.19 0.17
Radiological grade 0.09 0.10 0.07 0.06
All P valuesO 0.05.As shown in Table II, there was no signiﬁcant correlation
between the WOMAC subscale scores and the patient’s
characteristics (age, marital status, education level, BMI,
duration of disease and radiological grade).
DATA QUALITY AND ACCEPTABILITY
All eligible subjects accepted to take part in the study.
Missing data for items were low (3.2%). Ninety-seven
percent of patients completed all 24 items (100% complete
data), 1.6% of patients missed out two physical function
items and 1.6% of patients missed out one physical function
item. We substituted the average value for the subscale in
lieu of missing item values as recommended by Dr
Bellamy11. Therefore, WOMAC index scores were com-
puted for 72 patients (100%). Average time to complete the
WOMAC index was 3.5 min, while it was 7.8 min for SF-36.
RELIABILITY
Cronbach’s alpha coefﬁcients for the three subscales at
Time 1 and Time 2 were as follows: Pain: 0.75, 0.81;
Stiffness: 0.71, 0.76; Physical function: 0.94, 0.96.
CONTENT VALIDITY
As shown in Table III, frequency distribution of scores on
each subscale of WOMAC index was quite symmetrical and
Table III
Content validity of WOMAC
WOMAC
subscales
Content validity
N Mean (SD) Floor
n (%)
Ceiling
n (%)
Skewness
Pain 72 4.1 (1.9) 1 (1.4) 0 0.13
Stiffness 72 3.7 (2.5) 14 (19.4) 0 0.18
Physical function 72 4.6 (2.0) 1 (1.4) 0 0.03
Total 72 12.4 (5.5) 0 0 0.01
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subscales had negligible ﬂoor and ceiling effects.
CONVERGENT AND DIVERGENT VALIDITY
Table IV shows Pearson’s correlation coefﬁcients be-
tween WOMAC subscales and SF-36 subscales, and
Lequesne index. Both pain and physical function subscales
of WOMAC index showed statistically signiﬁcant correlation
with the physical functioning and bodily pain subscales of
SF-36. Although correlation coefﬁcients are signiﬁcant at
0.01 levels, these two subscales had weak correlations with
the other dimensions of SF-36. There was a fairly good
correlation, at 0.01 signiﬁcant level, between the scores on
WOMAC total and Lequesne index.
RESPONSIVENESS
As shown in Table V, P values generated using
Wilcoxon’s test for isokinetic quadriceps exercise group
showed that there were signiﬁcant improvements at the end
of treatment period in all WOMAC subscales (all P
values! 0.01). Likewise, there were signiﬁcant improve-
ments for all subscales, except stiffness, in Time 2
compared to Time 1 for isotonic quadriceps exercise group.
Table IV
Convergent and divergent validity (Pearson’s correlation coefficient)
WOMAC subscales
Pain Stiffness Physical function Total
SF-36 subscales
Physical functioning 0.55 0.38 0.72 0.63
Role physical 0.36 0.47 0.48 0.52
Bodily pain 0.51 0.40 0.54 0.55
General health 0.34 0.34 0.49 0.45
Vitality 0.43 0.35 0.43 0.47
Role emotional 0.28 0.34 0.40 0.40
Social functioning 0.34 0.36 0.49 0.46
Mental health 0.40 0.31 0.37 0.42
Lequesne index 0.64 0.50 0.68 0.70
All P values! 0.01 (two tailed).In terms of SRM, the patients in group 1 showed large effect
in the pain, physical function, and total scores of WOMAC
index, whereas the patients in group 2 showed medium
effect. In terms of stiffness, the size of the effect was
medium in group 1, whereas it was small in group 2. In both
groups, the values of ES and SRM for Lequesne index were
greater than those calculated for WOMAC total.
Discussion
The use of measurement tools in physical therapy has
increased dramatically since early 1900s. For clinicians,
valid measurement tools provide important information to
support effective clinical interpretation. These instruments
helped to deﬁne the nature and scope of clinical problems,
provide standards against which to monitor progress, and
serve to summarize clinically important changes that occur
as a result of the therapy process. For any test or measure
of health status to be useful it must be reliable, valid,
responsive and acceptable. The WOMAC index has been
designed speciﬁcally to evaluate patients with OA of the
knee or hip. The English-language version of the original
index has been shown to be a reliable, valid, responsive
and acceptable outcome measure10,23. It has been trans-
lated into over 50 different languages including Turkish11.
However, to enable comparison between evaluations made
in different countries, this questionnaire needs not only to
be translated and linguistically validated, but also the
demonstration of its psychometric properties (reliability,
validity and sensitivity to change). Here, we present data on
metric properties of the Turkish version of WOMAC index.
In this study, we found that there was no signiﬁcant
correlation between WOMAC scores and age of patient.
Our result conﬁrms earlier observations that there was no
association between age and severity of pain and physical
function in OA24e26. We found that BMI was not associated
with WOMAC scores. This result is consistent with the
observation made by Dr Salafﬁ and co-workers20. While
many investigators suggested that formal education level
appear to be an important factor in self-reported pain
severity in knee OA20,25,26, we were unable to show
a signiﬁcant correlation between the educational level and
WOMAC scores. Although this ﬁnding shows that patient’sTable V
Changes in the WOMAC and Lequesne index scores for subjects in isokinetic quadriceps exercise program (group 1) and isotonic quadriceps
exercise program (group 2)
Mean (SD) P valuey ES SRM
Time 1 Time 2 Difference
Group 1
WOMAC subscales
Pain 4.5 (1.8) 2.9 (1.9) 1.6 (1.6) 0.001 0.88 1.00
Stiffness 3.9 (2.5) 2.8 (2.2) 1.1 (2.1) 0.009 0.44 0.52
Physical function 4.7 (1.9) 3.2 (2.1) 1.5 (1.6) 0.001 0.79 0.94
Total 13.1 (5.4) 8.9 (5.9) 4.2 (4.1) 0.001 0.78 1.02
Lequesne index 10.4 (4.1) 7.0 (4.8) 3.4 (2.9) 0.001 0.83 1.17
Group 2
WOMAC subscales
Pain 3.8 (1.9) 2.4 (1.8) 1.4 (1.8) 0.001 0.74 0.78
Stiffness 3.6 (2.5) 2.8 (2.2) 0.8 (2.8) 0.107 0.32 0.29
Physical function 4.4 (2.2) 3.3 (2.1) 1.1 (1.6) 0.001 0.50 0.69
Total 11.8 (5.5) 8.5 (5.3) 3.3 (4.7) 0.001 0.60 0.70
Lequesne index 10.1 (3.9) 6.8 (3.2) 3.3 (3.6) 0.001 0.85 0.92
ESZ effect size, SRMZ standardized response mean.
yWilcoxon’s test.
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the response to items in the questionnaire, further studies
are needed to conﬁrm our ﬁnding. In this study, we did not
ﬁnd a signiﬁcant correlation between the duration of OA and
WOMAC scores. This ﬁnding is consistent with the ﬁnding
of Dr Creamer and co-workers26. The ﬁndings of the
present study showed that functional disability and pain
severity were not correlated with radiographic damage. This
ﬁnding conﬁrms earlier observations on the association
between the radiographic severity and functional disability
and pain27e29.
In this study, we found that the non-response rate and the
rates of missing responses were quite low. The time taken
to ﬁll out WOMAC index was lesser than in SF-36. These
results showed that the Turkish version of WOMAC index is
an acceptable instrument to patients.
In this study, we found that Cronbach’s alpha values for
all subscales of WOMAC index exceed the suggested cutoff
value of 0.70, revealing an acceptable level of reliability for
group comparisons30. The alpha value of WOMAC stiffness
subscale was lower than all other subscale values. This
was an expected result, since the alpha value is dependent
on the number of items. The WOMAC stiffness subscale is
derived from only two questions, while the pain and physical
function subscales contain 5 and 17 items, respectively.
Similar ﬁndings have been reported for the Italian version20
and the Spanish version31.
The results of present study showed that the Turkish
version of WOMAC index has a minimal ﬂoor and ceiling
effects, as well as good frequency distribution of scores on
each subscale. This ﬁnding is consistent with such previous
studies32,33 and indicates that the Turkish version of
WOMAC index has a good content validity. Likewise,
correlation coefﬁcients between the Turkish version of
WOMAC index and both SF-36 and Lequesne index
demonstrated good convergent and divergent validity.
There were linear relationships between the pain subscale
of WOMAC index and the physical functioning subscale of
SF-36, and between the physical function subscale of
WOMAC index and the bodily pain of SF-36. This ﬁnding is
not surprising, since physical function in OA is closely
related with the pain34.
The self-report questionnaires are widely used for the
assessment of treatment outcomes in evaluation studies. In
these studies assessments are performed at various time
points and outcomes are presented as differences between
the baseline and follow-up measurements. There is growing
recognition that assessing an intervention’s effect should
not only focus at the statistical signiﬁcance of the differ-
ences in health outcome but also at the baseline and follow-
up measurements. If a P value is interpreted as statistically
signiﬁcant, rejecting the null hypothesis does not imply an
effect of important magnitude; likewise, a non-signiﬁcant P
value does not indicate a trivial result35,36. The results of
present study showed that after 2 weeks treatment period,
both treatment protocols are effective in reducing pain and
in increasing physical function. The pain and physical
function subscales of WOMAC index were the most
responsive subscales, with the highest ES and SRM
resulting in comparably smaller sample sizes required for
future studies. ES values for stiffness subscale were lower
than in the other subscales. This ﬁnding is consistent with
such previous studies37,38. One possible explanation for
this result may be that the reliability can spuriously affect the
ES. As the internal consistency decreases, within-group
variability increases, which means that between-group ES
decreases39. In a study conducted among ambulatorypatients undergoing hip or knee arthroplasty, it had been
found that WOMAC global index was more responsive than
Lequesne index40. On the contrary, our results showed that
Lequesne-Algofunctional Index of Severity for the knee was
more responsive than WOMAC total. The differences
between the results of two studies may be the result of
differences between treatment methods as well as the
differences in characteristics of study populations.
In conclusion, the Turkish WOMAC OA index is accept-
able, valid, reliable and responsive for use in Turkish
patients with OA of the knee in physiotherapy outpatient
practice.
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